Boston scientific synergy XD and megatron DES stents consignment agreement

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36C24223D0041
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 36C24223R0025 Solicitation number
Last date to order 100% complete
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs awarded Boston Scientific Corporation a single award indefinite delivery contract to provide surgical implants and related services in support of Veterans Health Administration programs. The contract has a potential value of up to $295 million over a five year ordering period, with no set-aside designations applied. Delivery orders issued to date total over $2.5 million.

Boston Scientific will supply a range of implantable medical devices under the contract. Based on the company's portfolio and previous federal contracts, this likely includes products for cardiac rhythm management such as pacemakers and implantable cardioverter defibrillators, as well as coronary and peripheral vascular stents. The contract also encompasses related supplies, equipment, and service requirements to support the implantation of these devices at VA medical centers nationwide. As the sole awardee, Boston Scientific is positioned to be the VA's primary provider of implantable cardiac devices and supplies through 2028, aiming to ensure Veterans have access to state-of-the-art treatments for conditions like arrhythmias and blockages in the arteries of the heart and blood vessels.

Additionally, the VA issued Boston Scientific a separate $3.5 million indefinite delivery contract for interventional radiology services and Yttrium-90 TheraSphere microspheres. Over $1.3 million in delivery orders were placed in the first year of that contract's period of performance, which extends through September 2028. The radiopharmaceutical microspheres are intended to treat cancerous tumors in the liver as a minimally invasive alternative to surgery. This award leverages Boston Scientific's expertise in brachytherapy to expand treatment options available to Veterans suffering from conditions like hepatocellular carcinoma.

Transactions

Action Obligated Date
Terminate for Convenience P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 36C24223D0041?

36C24223D0041 was awarded to Boston Scientific Corp by Veterans Integrated Service Network 2 (Veterans Health Administration) on February 7, 2023.

Who can order from contract 36C24223D0041?

36C24223D0041 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 36C24223D0041 competed?

The extent of competition for 36C24223D0041 was not available for competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV